MORBERG JOHN D (Chief Financial Officer) received a stock award from LIFECORE BIOMEDICAL, INC. \DE\
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 6/5/2023ACC: 0001628280-23-020839
Officer· Chief Financial Officer
Since Jan 2021
+95K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
95K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+45K
Price / share
—
Trade value
—
% of position
232.0%
6/1/2023
19.40K→64.40K
Common Stock
Direct
Shares
+50K
Price / share
—
Trade value
—
% of position
77.6%
6/1/2023
64.40K→114.40K
Total
Net shares
+95K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/1/2023 | A · Award | +45K | — | — | 232.0% | 19.40K | 64.40K |
| Common Stock Direct | 6/1/2023 | A · Award | +50K | — | — | 77.6% | 64.40K | 114.40K |
| Total | +95K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported